INVO Bioscience CFO Andrea Goren's 2022 pay jumps 109% to $596K
INVO Bioscience reports 2022 executive compensation
By ExecPay News
Published: November 24, 2023
INVO Bioscience reported fiscal year 2022 executive compensation information on November 24, 2023.
In 2022, three executives at INVO Bioscience received on average a compensation package of $476K, a 57% increase compared to previous year.
Average pay of disclosed executives at INVO Bioscience
Andrea Goren, Chief Financial Officer, received $596K in total, which increased by 109% compared to 2021. 61% of Goren's compensation, or $361K, was in option awards. Goren also received $215K in salary and $19K in stock awards.
Steven Shum, Chief Executive Officer, received a compensation package of $502K, which increased by 69% compared to previous year. 52% of the compensation package, or $260K, was in salary.
Michael Campbell, Chief Operating Officer, earned $330K in 2022, which is about the same as previous year.
Related executives
You may also like
Source: SEC filing on November 24, 2023.